Assessing medication burden and polypharmacy: finding the perfect measure
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Assessing medication burden to evaluate the quality of pharmacotherapy in older adults can be performed using a range of indicators including polypharmacy. Polypharmacy is a common term in the lite...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Even when the nature of symptoms is correctly interpreted, the renewed prescription of the same antidepressant drug or a switch to fluoxetine, which is less likely to induce withdrawal problems and is commonly suggested [59], may worsen the state of behavioral toxicity with subsequent episodes of refractoriness to treatment.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584 · cited 1×
“The algorithm to guide deprescribing process to reduce inappropriate polypharmacy in clinical practice has been proposed by the Australian Deprescribing Network [20].”
MethodSelf-citationTrends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176 · cited 1×
“when harms outweigh the benefits) in clinical practice [2].”
BackgroundSelf-citationReeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855 · cited 1×
“Deprescribing can be referred to as a process of withdrawing inappropriatemedications, supervised by a health-care professional with the goal of managing polypharmacy and improving patient outcomes [17].”
BackgroundSelf-citationInterventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review
Fried, T. R., O'Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13153 · Cited by 721 · cited 1×
“Evidence from systematic review of observational studies suggests that polypharmacy is linkedwith a range of prescribing and clinical outcomes including drug–drug interactions, medication non-adherence, inappropriate prescribing, adverse drug events, hospitalization, falls, functional decline, and mortality [7].”
BackgroundThe Effects of Polypharmacy in Older Adults
Hilmer, S., & Gnjidic, D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.224 · Cited by 362 · cited 1×
“Polypharmacy is a common term in the literature, but definitions vary from measuring total number of medications using various cutoffs to the use of high-risk or unnecessary medications [1].”
BackgroundSelf-citationHigh-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V, Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Le Couteur, D. G. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.258 · Cited by 303 · cited 1×
“7% of older Australian adults living in the community [3].”
BackgroundSelf-citationToo much medicine in older people? Deprescribing through shared decision making
Jansen, J., Naganathan, V., Carter, S. M., McLachlan, A. J., Nickel, B., Irwig, L., Bonner, C., Doust, J., Colvin, J., Heaney, A., et al. (2016) · BMJ · doi:10.1136/bmj.i2893 · Cited by 303 · cited 1×
“of shared decision-making and patient preferences in guiding deprescribing process has been recently highlighted, although implementation in the clinical practice may be challenging [21].”
BackgroundClinical assessment and management of multimorbidity: summary of NICE guidance
Farmer, C., Fenu, E., O’Flynn, N., & Guthrie, B. (2016) · BMJ · doi:10.1136/bmj.i4843 · Cited by 238 · cited 1×
“This has been acknowledged in the recent National Institute for Health and Care Excellence guidelines which provide recommendations for management of polypharmacy among people with multimorbidity [10].”
Method
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Understanding Health Attitudes and Behavior
Fava, G. A., Cosci, F., Sonino, N., & Guidi, J. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.10.019 · Cited by 72
Fall Risk-Increasing Drugs, Polypharmacy, and Falls Among Low-Income Community-Dwelling Older Adults
Ie, K., Chou, E., Boyce, R. D., & Albert, S. M. (2021) · Innovation in Aging · doi:10.1093/geroni/igab001 · Cited by 72
“It has been argued that the harm of polypharmacy may not consistently outweigh its benefit, depending on the appropriateness of medications prescribed (28).”
Background
Metadata
- Authors
- Gnjidic, D., Tinetti, M., & Allore, H. G.
- Affiliations
- The University of Sydney (AU)
- Yale University (US)
- Corresponding author
- Gnjidic, Danijela
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2017-03-08
- Volume
- 10
- Issue
- 4
- Pages
- 345-347
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- PMC
- PMC5477055
- OpenAlex
- W2594219652
- Cited by
- 54
- References
- 21
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 5 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 1
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-03-21)
- Open access
- bronze
- doi.org
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01 AG047891, R21 AG045148, P30 AG021342)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication burden, polypharmacy, older adults
- MeSH terms
- Aged, Humans, Practice Patterns, Physicians', Polypharmacy, Inappropriate Prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing medication burden and polypharmacy: finding the perfect measure. https://app.cochat.ai/papers/10.1080/17512433.2017.1301206
- The paper
- Gnjidic, D., Tinetti, M., & Allore, H. G. (2017). Assessing medication burden and polypharmacy: finding the perfect measure. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2017.1301206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.